Protein-based biomarkers in blood serum could classify individuals with Alzheimer's disease

An initial analysis suggests that biomarkers in blood serum can be combined with clinical information to accurately classify patients with Alzheimer's disease, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals.

Read the whole article on Physorg

More from Physorg